GALP: A Potential Drug Target Or Biomarker (G85569)

Target Name: GALP

NCBI ID: G85569

GALP

GALP: A Potential Drug Target Or Biomarker

GALP (Galanin-like peptide (isoform 1)) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is characterized by its unique structure, which is similar to that of the amino acid galanin, but with some differences in its sequence and function.

GALP has been shown to play a role in several biological processes, including insulin secretion, glucose tolerance, and the regulation of pain. It is also expressed in various diseases, including diabetes, obesity, and neuroinflammatory diseases.

As a result of its unique structure and function, GALP has potential as a drug target or biomarker. Researchers are exploring the use of GALP as a potential therapeutic agent for treating various diseases, including diabetes, obesity, and neuroinflammatory diseases.

One of the main advantages of GALP as a drug target is its ability to interact with other molecules in the body. GALP has been shown to interact with several proteins, including insulin, glucose transporter, and pain receptors. This makes it a potential target for drugs that work by modulating these interactions, such as insulin secretion, glucose tolerance, or pain perception.

GALP has also been shown to be involved in several biological processes that are related to the development and progression of diseases. For example, GALP has been shown to be involved in the regulation of pancreatic insulin secretion, which is important for maintaining normal blood sugar levels . It has also been shown to be involved in the regulation of body weight and appetite, which are important factors in the development of obesity and related diseases.

In addition to its potential as a drug target, GALP has also been shown to be a potential biomarker for several diseases. For example, GALP has been shown to be elevated in the blood of people with type 2 diabetes, which is a common disease that is associated with inflammation and insulin resistance. It has also been shown to be elevated in the blood of people with obesity, which is a disease that is associated with inflammation and insulin resistance.

Overall, GALP is a protein that has the potential to be a drug target or biomarker for several diseases. Researchers are currently exploring the use of GALP as a potential therapeutic agent for treating these diseases, and more research is needed to fully understand its function and potential.

Protein Name: Galanin Like Peptide

Functions: Hypothalamic neuropeptide which binds to the G-protein-coupled galanin receptors (GALR1, GALR2 and GALR3). Involved in a large number of putative physiological functions in CNS homeostatic processes, including the regulation of gonadotropin-releasing hormone secretion

The "GALP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GALP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets